Mohammad S. Rostami

Array ( [id] => 6064180 [patent_doc_number] => 20020032185 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-03-14 [patent_title] => 'Agent for treating parkinson\'s disease comprising astrocyte function-improving agent as active ingredient' [patent_app_type] => new [patent_app_number] => 09/906065 [patent_app_country] => US [patent_app_date] => 2001-07-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 2495 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 25 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0032/20020032185.pdf [firstpage_image] =>[orig_patent_app_number] => 09906065 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1300601 [patent_doc_number] => 06624202 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2003-09-23 [patent_title] => 'Inhibitors of copper-containing amine oxidases' [patent_app_type] => B2 [patent_app_number] => 09/898003 [patent_app_country] => US [patent_app_date] => 2001-07-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 11356 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 221 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/624/06624202.pdf [firstpage_image] =>[orig_patent_app_number] => 09898003 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1340829 [patent_doc_number] => 06589938 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2003-07-08 [patent_title] => 'Use of angiotensin I derivatives as an agent for the treatment and prevention of infarction-related cardiac injuries and disorders' [patent_app_type] => B2 [patent_app_number] => 09/895273 [patent_app_country] => US [patent_app_date] => 2001-06-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4403 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 14 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/589/06589938.pdf [firstpage_image] =>[orig_patent_app_number] => 09895273 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6716508 [patent_doc_number] => 20030027856 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-02-06 [patent_title] => 'Tolterodine metabolites' [patent_app_type] => new [patent_app_number] => 09/895463 [patent_app_country] => US [patent_app_date] => 2001-06-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3584 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 86 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0027/20030027856.pdf [firstpage_image] =>[orig_patent_app_number] => 09895463 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1402022 [patent_doc_number] => 06538037 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2003-03-25 [patent_title] => 'Methods for preparation and use of 1,24(S)-dihydroxyvitamin D2' [patent_app_type] => B2 [patent_app_number] => 09/891963 [patent_app_country] => US [patent_app_date] => 2001-06-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 13983 [patent_no_of_claims] => 82 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 27 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/538/06538037.pdf [firstpage_image] =>[orig_patent_app_number] => 09891963 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1459994 [patent_doc_number] => 06391875 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2002-05-21 [patent_title] => 'Pharmaceutically active morpholinol' [patent_app_type] => B2 [patent_app_number] => 09/886391 [patent_app_country] => US [patent_app_date] => 2001-06-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 4446 [patent_no_of_claims] => 1 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 34 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/391/06391875.pdf [firstpage_image] =>[orig_patent_app_number] => 09886391 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6625930 [patent_doc_number] => 20020016371 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-02-07 [patent_title] => 'Exo-S-mecamylamine formulation and use in treatment' [patent_app_type] => new [patent_app_number] => 09/882935 [patent_app_country] => US [patent_app_date] => 2001-06-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 12855 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 36 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0016/20020016371.pdf [firstpage_image] =>[orig_patent_app_number] => 09882935 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5936754 [patent_doc_number] => 20020061931 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-05-23 [patent_title] => 'Stable gabapentin containing more than 20 ppm of chlorine ion' [patent_app_type] => new [patent_app_number] => 09/880854 [patent_app_country] => US [patent_app_date] => 2001-06-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5273 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 55 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0061/20020061931.pdf [firstpage_image] =>[orig_patent_app_number] => 09880854 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5889086 [patent_doc_number] => 20020013295 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-01-31 [patent_title] => 'Naaladase inhibitors for treating amyotrophic lateral sclerosis' [patent_app_type] => new [patent_app_number] => 09/866729 [patent_app_country] => US [patent_app_date] => 2001-05-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 11469 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 25 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0013/20020013295.pdf [firstpage_image] =>[orig_patent_app_number] => 09866729 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5952259 [patent_doc_number] => 20020007055 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-01-17 [patent_title] => 'Compositions comprising cyclodextrin' [patent_app_type] => new [patent_app_number] => 09/855440 [patent_app_country] => US [patent_app_date] => 2001-05-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 15337 [patent_no_of_claims] => 52 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 36 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0007/20020007055.pdf [firstpage_image] =>[orig_patent_app_number] => 09855440 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1420809 [patent_doc_number] => 06515022 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2003-02-04 [patent_title] => 'Use of inhaled retinoids in the treatment of lung diseases' [patent_app_type] => B2 [patent_app_number] => 09/854331 [patent_app_country] => US [patent_app_date] => 2001-05-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 5 [patent_no_of_words] => 3944 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 42 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/515/06515022.pdf [firstpage_image] =>[orig_patent_app_number] => 09854331 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7078213 [patent_doc_number] => 20010041191 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2001-11-15 [patent_title] => 'Use of magnesium based products for the treatment of neoplasti diseases' [patent_app_type] => new [patent_app_number] => 09/852619 [patent_app_country] => US [patent_app_date] => 2001-05-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5509 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 13 [patent_words_short_claim] => 17 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0041/20010041191.pdf [firstpage_image] =>[orig_patent_app_number] => 09852619 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6000658 [patent_doc_number] => 20020028815 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-03-07 [patent_title] => 'Novel multicyclic compounds and the use thereof' [patent_app_type] => new [patent_app_number] => 09/850858 [patent_app_country] => US [patent_app_date] => 2001-05-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 55389 [patent_no_of_claims] => 34 [patent_no_of_ind_claims] => 12 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0028/20020028815.pdf [firstpage_image] =>[orig_patent_app_number] => 09850858 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7636451 [patent_doc_number] => 06380206 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-04-30 [patent_title] => 'Method of inhibiting neoplastic cells with 4,5-diaminopyrimidine derivatives' [patent_app_type] => B1 [patent_app_number] => 09/850510 [patent_app_country] => US [patent_app_date] => 2001-05-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 9492 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 23 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/380/06380206.pdf [firstpage_image] =>[orig_patent_app_number] => 09850510 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6439839 [patent_doc_number] => 20020128267 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-09-12 [patent_title] => 'Method of using COX-2 inhibitors in the treatment and prevention of ocular COX-2 mediated disorders' [patent_app_type] => new [patent_app_number] => 09/849683 [patent_app_country] => US [patent_app_date] => 2001-05-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 19446 [patent_no_of_claims] => 39 [patent_no_of_ind_claims] => 11 [patent_words_short_claim] => 51 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0128/20020128267.pdf [firstpage_image] =>[orig_patent_app_number] => 09849683 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7001041 [patent_doc_number] => 20010053772 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2001-12-20 [patent_title] => 'Aza analogues of alkyl lysophospholipids exert immunomodulatory effects' [patent_app_type] => new [patent_app_number] => 09/846466 [patent_app_country] => US [patent_app_date] => 2001-04-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 8098 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 28 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0053/20010053772.pdf [firstpage_image] =>[orig_patent_app_number] => 09846466 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1446963 [patent_doc_number] => 06369092 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-04-09 [patent_title] => 'Method for treating neoplasia by exposure to substituted benzimidazole derivatives' [patent_app_type] => B1 [patent_app_number] => 09/845501 [patent_app_country] => US [patent_app_date] => 2001-04-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7410 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 23 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/369/06369092.pdf [firstpage_image] =>[orig_patent_app_number] => 09845501 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6131624 [patent_doc_number] => 20020077349 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-06-20 [patent_title] => 'Method of treating age-related vision impairment' [patent_app_type] => new [patent_app_number] => 09/844485 [patent_app_country] => US [patent_app_date] => 2001-04-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4570 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 28 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0077/20020077349.pdf [firstpage_image] =>[orig_patent_app_number] => 09844485 [rel_patent_id] =>[rel_patent_doc_number] =>)